Aiko Nagayama
5PUBLICATIONS
60CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 01, 2024
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer.Yuko Kawai, Aiko Nagayama, Kazuhiro Miyao
|May 07, 2024
Author Correction: Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair.Yumin Wang, Boya Gao, Luyuan Zhang
|May 06, 2024
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer.Aditya Bardia, Sheng Sun, Nayana Thimmiah
|Feb 22, 2024
PRMT1 Sustains De Novo Fatty Acid Synthesis by Methylating PHGDH to Drive Chemoresistance in Triple-Negative Breast Cancer.Takehiro Yamamoto, Tetsu Hayashida, Yohei Masugi
|Feb 21, 2024
Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair.Yumin Wang, Boya Gao, Luyuan Zhang
Pageof 1
Frequent Collaborators
3 joint publications
Leif W Ellisen
2 joint publications
Yumin Wang
2 joint publications
Xiaolan Zhu
2 joint publications
Sanghoon Lee
2 joint publications
Siang-Boon Koh
2 joint publications
Bo R Rueda
2 joint publications
Lee Zou
2 joint publications
Oladapo Yeku
2 joint publications
Xiao-Song Wang
2 joint publications
Li Lan
